nodes	percent_of_prediction	percent_of_DWPC	metapath
Orlistat—CYP3A4—Chenodeoxycholic acid—primary biliary cirrhosis	0.101	0.664	CbGbCtD
Orlistat—CYP3A4—Colchicine—primary biliary cirrhosis	0.0511	0.336	CbGbCtD
Orlistat—Appetite absent—Colchicine—primary biliary cirrhosis	0.0134	0.0227	CcSEcCtD
Orlistat—Gastrointestinal symptom NOS—Colchicine—primary biliary cirrhosis	0.0114	0.0192	CcSEcCtD
Orlistat—Cholecystitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.0104	0.0176	CcSEcCtD
Orlistat—Cholecystitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.0104	0.0176	CcSEcCtD
Orlistat—Hypothyroidism—Colchicine—primary biliary cirrhosis	0.0104	0.0176	CcSEcCtD
Orlistat—Blood disorder—Colchicine—primary biliary cirrhosis	0.00799	0.0135	CcSEcCtD
Orlistat—Acne—Ursodeoxycholic acid—primary biliary cirrhosis	0.00713	0.012	CcSEcCtD
Orlistat—Acne—Chenodeoxycholic acid—primary biliary cirrhosis	0.00713	0.012	CcSEcCtD
Orlistat—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51B—primary biliary cirrhosis	0.00701	0.0279	CbGpPWpGaD
Orlistat—PLA2G7—IL1 and megakaryotyces in obesity—MMP9—primary biliary cirrhosis	0.00694	0.0276	CbGpPWpGaD
Orlistat—PLA2G7—IL1 and megakaryotyces in obesity—NFKB1—primary biliary cirrhosis	0.00687	0.0273	CbGpPWpGaD
Orlistat—Cardiovascular disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00683	0.0115	CcSEcCtD
Orlistat—Cardiovascular disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00683	0.0115	CcSEcCtD
Orlistat—PLA2G7—Peptide hormone metabolism—ACE—primary biliary cirrhosis	0.00676	0.0269	CbGpPWpGaD
Orlistat—Dysmenorrhoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.0066	0.0111	CcSEcCtD
Orlistat—Dysmenorrhoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.0066	0.0111	CcSEcCtD
Orlistat—Drug interaction—Chenodeoxycholic acid—primary biliary cirrhosis	0.00647	0.0109	CcSEcCtD
Orlistat—Drug interaction—Ursodeoxycholic acid—primary biliary cirrhosis	0.00647	0.0109	CcSEcCtD
Orlistat—Vaginal inflammation—Ursodeoxycholic acid—primary biliary cirrhosis	0.006	0.0101	CcSEcCtD
Orlistat—Vaginal inflammation—Chenodeoxycholic acid—primary biliary cirrhosis	0.006	0.0101	CcSEcCtD
Orlistat—Eructation—Ursodeoxycholic acid—primary biliary cirrhosis	0.00589	0.00995	CcSEcCtD
Orlistat—Eructation—Chenodeoxycholic acid—primary biliary cirrhosis	0.00589	0.00995	CcSEcCtD
Orlistat—Vaginal infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.00566	0.00956	CcSEcCtD
Orlistat—Vaginal infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.00566	0.00956	CcSEcCtD
Orlistat—Cramps of lower extremities—Ursodeoxycholic acid—primary biliary cirrhosis	0.00551	0.0093	CcSEcCtD
Orlistat—Cramps of lower extremities—Chenodeoxycholic acid—primary biliary cirrhosis	0.00551	0.0093	CcSEcCtD
Orlistat—Neoplasm—Chenodeoxycholic acid—primary biliary cirrhosis	0.00542	0.00916	CcSEcCtD
Orlistat—Neoplasm—Ursodeoxycholic acid—primary biliary cirrhosis	0.00542	0.00916	CcSEcCtD
Orlistat—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51A—primary biliary cirrhosis	0.00531	0.0211	CbGpPWpGaD
Orlistat—Sleep disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00503	0.00849	CcSEcCtD
Orlistat—Sleep disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00503	0.00849	CcSEcCtD
Orlistat—Arthritis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00448	0.00756	CcSEcCtD
Orlistat—Arthritis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00448	0.00756	CcSEcCtD
Orlistat—Cramp muscle—Colchicine—primary biliary cirrhosis	0.00436	0.00737	CcSEcCtD
Orlistat—PLA2G7—Peptide hormone metabolism—AGT—primary biliary cirrhosis	0.00428	0.017	CbGpPWpGaD
Orlistat—Abdominal discomfort—Colchicine—primary biliary cirrhosis	0.00401	0.00678	CcSEcCtD
Orlistat—Abdominal pain upper—Ursodeoxycholic acid—primary biliary cirrhosis	0.00398	0.00671	CcSEcCtD
Orlistat—Abdominal pain upper—Chenodeoxycholic acid—primary biliary cirrhosis	0.00398	0.00671	CcSEcCtD
Orlistat—Breast disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00393	0.00664	CcSEcCtD
Orlistat—Breast disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00393	0.00664	CcSEcCtD
Orlistat—Cramp muscle—Ursodeoxycholic acid—primary biliary cirrhosis	0.00392	0.00662	CcSEcCtD
Orlistat—Cramp muscle—Chenodeoxycholic acid—primary biliary cirrhosis	0.00392	0.00662	CcSEcCtD
Orlistat—Gastritis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00385	0.00651	CcSEcCtD
Orlistat—Gastritis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00385	0.00651	CcSEcCtD
Orlistat—Influenza—Ursodeoxycholic acid—primary biliary cirrhosis	0.00376	0.00635	CcSEcCtD
Orlistat—Influenza—Chenodeoxycholic acid—primary biliary cirrhosis	0.00376	0.00635	CcSEcCtD
Orlistat—Asthma—Chenodeoxycholic acid—primary biliary cirrhosis	0.00376	0.00635	CcSEcCtD
Orlistat—Asthma—Ursodeoxycholic acid—primary biliary cirrhosis	0.00376	0.00635	CcSEcCtD
Orlistat—Pancreatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00369	0.00623	CcSEcCtD
Orlistat—Pancreatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00369	0.00623	CcSEcCtD
Orlistat—FASN—Fatty acid, triacylglycerol, and ketone body metabolism—ABCB4—primary biliary cirrhosis	0.00367	0.0146	CbGpPWpGaD
Orlistat—Neuropathy peripheral—Colchicine—primary biliary cirrhosis	0.00366	0.00618	CcSEcCtD
Orlistat—Abdominal discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.00361	0.00609	CcSEcCtD
Orlistat—Abdominal discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.00361	0.00609	CcSEcCtD
Orlistat—Upper respiratory tract infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.0035	0.00591	CcSEcCtD
Orlistat—Upper respiratory tract infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.0035	0.00591	CcSEcCtD
Orlistat—PNLIP—Metabolism of lipids and lipoproteins—LBR—primary biliary cirrhosis	0.00341	0.0136	CbGpPWpGaD
Orlistat—Infestation—Chenodeoxycholic acid—primary biliary cirrhosis	0.00336	0.00567	CcSEcCtD
Orlistat—Infestation NOS—Ursodeoxycholic acid—primary biliary cirrhosis	0.00336	0.00567	CcSEcCtD
Orlistat—Infestation—Ursodeoxycholic acid—primary biliary cirrhosis	0.00336	0.00567	CcSEcCtD
Orlistat—Infestation NOS—Chenodeoxycholic acid—primary biliary cirrhosis	0.00336	0.00567	CcSEcCtD
Orlistat—Depression—Chenodeoxycholic acid—primary biliary cirrhosis	0.00335	0.00565	CcSEcCtD
Orlistat—Depression—Ursodeoxycholic acid—primary biliary cirrhosis	0.00335	0.00565	CcSEcCtD
Orlistat—Renal failure—Chenodeoxycholic acid—primary biliary cirrhosis	0.0033	0.00557	CcSEcCtD
Orlistat—Renal failure—Ursodeoxycholic acid—primary biliary cirrhosis	0.0033	0.00557	CcSEcCtD
Orlistat—PLA2G4A—Platelet homeostasis—PDE5A—primary biliary cirrhosis	0.00327	0.013	CbGpPWpGaD
Orlistat—Urinary tract infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.00326	0.00551	CcSEcCtD
Orlistat—Urinary tract infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.00326	0.00551	CcSEcCtD
Orlistat—Hepatobiliary disease—Ursodeoxycholic acid—primary biliary cirrhosis	0.00317	0.00536	CcSEcCtD
Orlistat—Hepatobiliary disease—Chenodeoxycholic acid—primary biliary cirrhosis	0.00317	0.00536	CcSEcCtD
Orlistat—PNLIP—Lipid and lipoprotein metabolism—ALB—primary biliary cirrhosis	0.00316	0.0125	CbGpPWpGaD
Orlistat—Sinusitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00315	0.00532	CcSEcCtD
Orlistat—Sinusitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00315	0.00532	CcSEcCtD
Orlistat—DAGLB—Hemostasis—RAD51B—primary biliary cirrhosis	0.00314	0.0125	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—RAD51B—primary biliary cirrhosis	0.00314	0.0125	CbGpPWpGaD
Orlistat—Haemoglobin—Chenodeoxycholic acid—primary biliary cirrhosis	0.00303	0.00511	CcSEcCtD
Orlistat—Haemoglobin—Ursodeoxycholic acid—primary biliary cirrhosis	0.00303	0.00511	CcSEcCtD
Orlistat—Mediastinal disorder—Colchicine—primary biliary cirrhosis	0.00302	0.0051	CcSEcCtD
Orlistat—Haemorrhage—Ursodeoxycholic acid—primary biliary cirrhosis	0.00301	0.00509	CcSEcCtD
Orlistat—Haemorrhage—Chenodeoxycholic acid—primary biliary cirrhosis	0.00301	0.00509	CcSEcCtD
Orlistat—Pharyngitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00299	0.00505	CcSEcCtD
Orlistat—Pharyngitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00299	0.00505	CcSEcCtD
Orlistat—Urinary tract disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00297	0.00502	CcSEcCtD
Orlistat—Urinary tract disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00297	0.00502	CcSEcCtD
Orlistat—Oedema peripheral—Ursodeoxycholic acid—primary biliary cirrhosis	0.00297	0.00501	CcSEcCtD
Orlistat—Oedema peripheral—Chenodeoxycholic acid—primary biliary cirrhosis	0.00297	0.00501	CcSEcCtD
Orlistat—Alopecia—Colchicine—primary biliary cirrhosis	0.00296	0.005	CcSEcCtD
Orlistat—Urethral disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00295	0.00499	CcSEcCtD
Orlistat—Urethral disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00295	0.00499	CcSEcCtD
Orlistat—CYP3A4—Codeine and Morphine Metabolism—ABCC2—primary biliary cirrhosis	0.00293	0.0116	CbGpPWpGaD
Orlistat—Malnutrition—Colchicine—primary biliary cirrhosis	0.00292	0.00493	CcSEcCtD
Orlistat—DAGLB—Hemostasis—PDE5A—primary biliary cirrhosis	0.00292	0.0116	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—PDE5A—primary biliary cirrhosis	0.00292	0.0116	CbGpPWpGaD
Orlistat—Muscle spasms—Colchicine—primary biliary cirrhosis	0.00281	0.00474	CcSEcCtD
Orlistat—Immune system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00272	0.00459	CcSEcCtD
Orlistat—Immune system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00272	0.00459	CcSEcCtD
Orlistat—Mediastinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00271	0.00458	CcSEcCtD
Orlistat—Mediastinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00271	0.00458	CcSEcCtD
Orlistat—PLA2G7—Metabolism of proteins—ACE2—primary biliary cirrhosis	0.0027	0.0107	CbGpPWpGaD
Orlistat—Angioedema—Colchicine—primary biliary cirrhosis	0.00267	0.0045	CcSEcCtD
Orlistat—Alopecia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00266	0.00449	CcSEcCtD
Orlistat—Alopecia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00266	0.00449	CcSEcCtD
Orlistat—Malnutrition—Ursodeoxycholic acid—primary biliary cirrhosis	0.00262	0.00443	CcSEcCtD
Orlistat—Malnutrition—Chenodeoxycholic acid—primary biliary cirrhosis	0.00262	0.00443	CcSEcCtD
Orlistat—FASN—AMPK Signaling—RPS6KB1—primary biliary cirrhosis	0.00261	0.0104	CbGpPWpGaD
Orlistat—Flatulence—Chenodeoxycholic acid—primary biliary cirrhosis	0.00258	0.00436	CcSEcCtD
Orlistat—Flatulence—Ursodeoxycholic acid—primary biliary cirrhosis	0.00258	0.00436	CcSEcCtD
Orlistat—Back pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00254	0.00428	CcSEcCtD
Orlistat—Back pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00254	0.00428	CcSEcCtD
Orlistat—Muscle spasms—Chenodeoxycholic acid—primary biliary cirrhosis	0.00252	0.00426	CcSEcCtD
Orlistat—Muscle spasms—Ursodeoxycholic acid—primary biliary cirrhosis	0.00252	0.00426	CcSEcCtD
Orlistat—Myalgia—Colchicine—primary biliary cirrhosis	0.00248	0.0042	CcSEcCtD
Orlistat—Ill-defined disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00243	0.00411	CcSEcCtD
Orlistat—Ill-defined disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00243	0.00411	CcSEcCtD
Orlistat—FASN—Metabolism of lipids and lipoproteins—LBR—primary biliary cirrhosis	0.00242	0.0096	CbGpPWpGaD
Orlistat—Angioedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.0024	0.00405	CcSEcCtD
Orlistat—Angioedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.0024	0.00405	CcSEcCtD
Orlistat—Malaise—Ursodeoxycholic acid—primary biliary cirrhosis	0.00236	0.00399	CcSEcCtD
Orlistat—Malaise—Chenodeoxycholic acid—primary biliary cirrhosis	0.00236	0.00399	CcSEcCtD
Orlistat—Vertigo—Ursodeoxycholic acid—primary biliary cirrhosis	0.00236	0.00398	CcSEcCtD
Orlistat—Vertigo—Chenodeoxycholic acid—primary biliary cirrhosis	0.00236	0.00398	CcSEcCtD
Orlistat—Nervous system disorder—Colchicine—primary biliary cirrhosis	0.00234	0.00394	CcSEcCtD
Orlistat—Palpitations—Ursodeoxycholic acid—primary biliary cirrhosis	0.00232	0.00391	CcSEcCtD
Orlistat—Palpitations—Chenodeoxycholic acid—primary biliary cirrhosis	0.00232	0.00391	CcSEcCtD
Orlistat—Skin disorder—Colchicine—primary biliary cirrhosis	0.00231	0.00391	CcSEcCtD
Orlistat—Cough—Ursodeoxycholic acid—primary biliary cirrhosis	0.00229	0.00386	CcSEcCtD
Orlistat—Cough—Chenodeoxycholic acid—primary biliary cirrhosis	0.00229	0.00386	CcSEcCtD
Orlistat—Convulsion—Chenodeoxycholic acid—primary biliary cirrhosis	0.00227	0.00384	CcSEcCtD
Orlistat—Convulsion—Ursodeoxycholic acid—primary biliary cirrhosis	0.00227	0.00384	CcSEcCtD
Orlistat—Chest pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00223	0.00377	CcSEcCtD
Orlistat—Myalgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00223	0.00377	CcSEcCtD
Orlistat—Chest pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00223	0.00377	CcSEcCtD
Orlistat—Myalgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00223	0.00377	CcSEcCtD
Orlistat—CYP3A4—Farnesoid X Receptor  Pathway—ABCB4—primary biliary cirrhosis	0.00223	0.00887	CbGpPWpGaD
Orlistat—Unspecified disorder of skin and subcutaneous tissue—Chenodeoxycholic acid—primary biliary cirrhosis	0.00222	0.00374	CcSEcCtD
Orlistat—Unspecified disorder of skin and subcutaneous tissue—Ursodeoxycholic acid—primary biliary cirrhosis	0.00222	0.00374	CcSEcCtD
Orlistat—Discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.00221	0.00372	CcSEcCtD
Orlistat—Discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.00221	0.00372	CcSEcCtD
Orlistat—Dry mouth—Chenodeoxycholic acid—primary biliary cirrhosis	0.00218	0.00369	CcSEcCtD
Orlistat—Dry mouth—Ursodeoxycholic acid—primary biliary cirrhosis	0.00218	0.00369	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Colchicine—primary biliary cirrhosis	0.00217	0.00366	CcSEcCtD
Orlistat—Oedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.00214	0.00361	CcSEcCtD
Orlistat—Oedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.00214	0.00361	CcSEcCtD
Orlistat—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—PPARGC1A—primary biliary cirrhosis	0.00213	0.00848	CbGpPWpGaD
Orlistat—Infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.00213	0.00359	CcSEcCtD
Orlistat—Infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.00213	0.00359	CcSEcCtD
Orlistat—Nervous system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.0021	0.00354	CcSEcCtD
Orlistat—Nervous system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.0021	0.00354	CcSEcCtD
Orlistat—PLA2G4A—AGE/RAGE pathway—ALPL—primary biliary cirrhosis	0.00208	0.00827	CbGpPWpGaD
Orlistat—Skin disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00208	0.00351	CcSEcCtD
Orlistat—Skin disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00208	0.00351	CcSEcCtD
Orlistat—Decreased appetite—Colchicine—primary biliary cirrhosis	0.00207	0.0035	CcSEcCtD
Orlistat—Hyperhidrosis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00207	0.00349	CcSEcCtD
Orlistat—Hyperhidrosis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00207	0.00349	CcSEcCtD
Orlistat—PNLIP—Metabolism of lipids and lipoproteins—ABCB4—primary biliary cirrhosis	0.00207	0.00822	CbGpPWpGaD
Orlistat—Gastrointestinal disorder—Colchicine—primary biliary cirrhosis	0.00206	0.00347	CcSEcCtD
Orlistat—Fatigue—Colchicine—primary biliary cirrhosis	0.00205	0.00347	CcSEcCtD
Orlistat—PLA2G7—Metabolism of proteins—REN—primary biliary cirrhosis	0.00204	0.00813	CbGpPWpGaD
Orlistat—DAGLA—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—primary biliary cirrhosis	0.00196	0.00778	CbGpPWpGaD
Orlistat—DAGLB—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—primary biliary cirrhosis	0.00196	0.00778	CbGpPWpGaD
Orlistat—Musculoskeletal discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.00195	0.00329	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.00195	0.00329	CcSEcCtD
Orlistat—Gastrointestinal pain—Colchicine—primary biliary cirrhosis	0.00195	0.00329	CcSEcCtD
Orlistat—Insomnia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00194	0.00327	CcSEcCtD
Orlistat—Insomnia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00194	0.00327	CcSEcCtD
Orlistat—Paraesthesia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00192	0.00324	CcSEcCtD
Orlistat—Paraesthesia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00192	0.00324	CcSEcCtD
Orlistat—PLA2G4A—AGE/RAGE pathway—MMP13—primary biliary cirrhosis	0.00189	0.00752	CbGpPWpGaD
Orlistat—Urticaria—Colchicine—primary biliary cirrhosis	0.00189	0.00319	CcSEcCtD
Orlistat—Dyspepsia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00188	0.00318	CcSEcCtD
Orlistat—Dyspepsia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00188	0.00318	CcSEcCtD
Orlistat—Abdominal pain—Colchicine—primary biliary cirrhosis	0.00188	0.00318	CcSEcCtD
Orlistat—CYP3A4—Irinotecan Pathway—ABCC2—primary biliary cirrhosis	0.00187	0.00744	CbGpPWpGaD
Orlistat—Decreased appetite—Chenodeoxycholic acid—primary biliary cirrhosis	0.00186	0.00314	CcSEcCtD
Orlistat—Decreased appetite—Ursodeoxycholic acid—primary biliary cirrhosis	0.00186	0.00314	CcSEcCtD
Orlistat—Gastrointestinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00185	0.00312	CcSEcCtD
Orlistat—Gastrointestinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00185	0.00312	CcSEcCtD
Orlistat—Fatigue—Chenodeoxycholic acid—primary biliary cirrhosis	0.00184	0.00312	CcSEcCtD
Orlistat—Fatigue—Ursodeoxycholic acid—primary biliary cirrhosis	0.00184	0.00312	CcSEcCtD
Orlistat—Pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00183	0.00309	CcSEcCtD
Orlistat—Pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00183	0.00309	CcSEcCtD
Orlistat—PLA2G4A—Arachidonic acid metabolism—GGT1—primary biliary cirrhosis	0.0018	0.00716	CbGpPWpGaD
Orlistat—PLA2G7—Metabolism of proteins—IGFBP1—primary biliary cirrhosis	0.00178	0.00709	CbGpPWpGaD
Orlistat—Feeling abnormal—Chenodeoxycholic acid—primary biliary cirrhosis	0.00176	0.00298	CcSEcCtD
Orlistat—Feeling abnormal—Ursodeoxycholic acid—primary biliary cirrhosis	0.00176	0.00298	CcSEcCtD
Orlistat—FASN—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—primary biliary cirrhosis	0.00176	0.007	CbGpPWpGaD
Orlistat—Hypersensitivity—Colchicine—primary biliary cirrhosis	0.00175	0.00296	CcSEcCtD
Orlistat—Gastrointestinal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00175	0.00295	CcSEcCtD
Orlistat—Gastrointestinal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00175	0.00295	CcSEcCtD
Orlistat—DAGLA—G alpha (q) signalling events—AGT—primary biliary cirrhosis	0.00173	0.00687	CbGpPWpGaD
Orlistat—DAGLB—G alpha (q) signalling events—AGT—primary biliary cirrhosis	0.00173	0.00687	CbGpPWpGaD
Orlistat—Asthenia—Colchicine—primary biliary cirrhosis	0.00171	0.00289	CcSEcCtD
Orlistat—Urticaria—Ursodeoxycholic acid—primary biliary cirrhosis	0.0017	0.00287	CcSEcCtD
Orlistat—Urticaria—Chenodeoxycholic acid—primary biliary cirrhosis	0.0017	0.00287	CcSEcCtD
Orlistat—Body temperature increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00169	0.00286	CcSEcCtD
Orlistat—Abdominal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00169	0.00286	CcSEcCtD
Orlistat—Body temperature increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00169	0.00286	CcSEcCtD
Orlistat—Abdominal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00169	0.00286	CcSEcCtD
Orlistat—Diarrhoea—Colchicine—primary biliary cirrhosis	0.00163	0.00275	CcSEcCtD
Orlistat—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC2—primary biliary cirrhosis	0.0016	0.00637	CbGpPWpGaD
Orlistat—CYP3A4—Irinotecan Pathway—ABCG2—primary biliary cirrhosis	0.00159	0.00633	CbGpPWpGaD
Orlistat—Hypersensitivity—Chenodeoxycholic acid—primary biliary cirrhosis	0.00158	0.00266	CcSEcCtD
Orlistat—Hypersensitivity—Ursodeoxycholic acid—primary biliary cirrhosis	0.00158	0.00266	CcSEcCtD
Orlistat—DAGLA—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—primary biliary cirrhosis	0.00155	0.00614	CbGpPWpGaD
Orlistat—DAGLB—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—primary biliary cirrhosis	0.00155	0.00614	CbGpPWpGaD
Orlistat—Asthenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00154	0.00259	CcSEcCtD
Orlistat—Asthenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00154	0.00259	CcSEcCtD
Orlistat—PNLIP—Metabolism—LBR—primary biliary cirrhosis	0.00152	0.00604	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—NOS2—primary biliary cirrhosis	0.00152	0.00603	CbGpPWpGaD
Orlistat—Vomiting—Colchicine—primary biliary cirrhosis	0.00151	0.00256	CcSEcCtD
Orlistat—Pruritus—Ursodeoxycholic acid—primary biliary cirrhosis	0.00151	0.00256	CcSEcCtD
Orlistat—Pruritus—Chenodeoxycholic acid—primary biliary cirrhosis	0.00151	0.00256	CcSEcCtD
Orlistat—Rash—Colchicine—primary biliary cirrhosis	0.0015	0.00254	CcSEcCtD
Orlistat—Dermatitis—Colchicine—primary biliary cirrhosis	0.0015	0.00253	CcSEcCtD
Orlistat—Headache—Colchicine—primary biliary cirrhosis	0.00149	0.00252	CcSEcCtD
Orlistat—Diarrhoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.00146	0.00247	CcSEcCtD
Orlistat—Diarrhoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.00146	0.00247	CcSEcCtD
Orlistat—FASN—Metabolism of lipids and lipoproteins—ABCB4—primary biliary cirrhosis	0.00146	0.00582	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—CXCR5—primary biliary cirrhosis	0.00145	0.00575	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—CXCR5—primary biliary cirrhosis	0.00145	0.00575	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—DAG1—primary biliary cirrhosis	0.00143	0.00567	CbGpPWpGaD
Orlistat—Dizziness—Chenodeoxycholic acid—primary biliary cirrhosis	0.00142	0.00239	CcSEcCtD
Orlistat—Dizziness—Ursodeoxycholic acid—primary biliary cirrhosis	0.00142	0.00239	CcSEcCtD
Orlistat—Nausea—Colchicine—primary biliary cirrhosis	0.00141	0.00239	CcSEcCtD
Orlistat—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—primary biliary cirrhosis	0.0014	0.00557	CbGpPWpGaD
Orlistat—Vomiting—Chenodeoxycholic acid—primary biliary cirrhosis	0.00136	0.0023	CcSEcCtD
Orlistat—Vomiting—Ursodeoxycholic acid—primary biliary cirrhosis	0.00136	0.0023	CcSEcCtD
Orlistat—Rash—Chenodeoxycholic acid—primary biliary cirrhosis	0.00135	0.00228	CcSEcCtD
Orlistat—Rash—Ursodeoxycholic acid—primary biliary cirrhosis	0.00135	0.00228	CcSEcCtD
Orlistat—Dermatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00135	0.00228	CcSEcCtD
Orlistat—Dermatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00135	0.00228	CcSEcCtD
Orlistat—FASN—Fatty acid, triacylglycerol, and ketone body metabolism—PPARGC1A—primary biliary cirrhosis	0.00134	0.00533	CbGpPWpGaD
Orlistat—Headache—Chenodeoxycholic acid—primary biliary cirrhosis	0.00134	0.00226	CcSEcCtD
Orlistat—Headache—Ursodeoxycholic acid—primary biliary cirrhosis	0.00134	0.00226	CcSEcCtD
Orlistat—DAGLA—Signaling by GPCR—CXCR5—primary biliary cirrhosis	0.00131	0.00522	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—CXCR5—primary biliary cirrhosis	0.00131	0.00522	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—CXCL9—primary biliary cirrhosis	0.00131	0.00522	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—CXCL9—primary biliary cirrhosis	0.00131	0.00522	CbGpPWpGaD
Orlistat—CYP3A4—Tryptophan metabolism—OGDH—primary biliary cirrhosis	0.00131	0.00522	CbGpPWpGaD
Orlistat—PLA2G7—Metabolism of proteins—ACE—primary biliary cirrhosis	0.00128	0.00507	CbGpPWpGaD
Orlistat—Nausea—Chenodeoxycholic acid—primary biliary cirrhosis	0.00127	0.00215	CcSEcCtD
Orlistat—Nausea—Ursodeoxycholic acid—primary biliary cirrhosis	0.00127	0.00215	CcSEcCtD
Orlistat—DAGLB—Signaling by GPCR—CXCL9—primary biliary cirrhosis	0.00119	0.00474	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—CXCL9—primary biliary cirrhosis	0.00119	0.00474	CbGpPWpGaD
Orlistat—DAGLA—Platelet activation, signaling and aggregation—ALB—primary biliary cirrhosis	0.00116	0.00461	CbGpPWpGaD
Orlistat—DAGLB—Platelet activation, signaling and aggregation—ALB—primary biliary cirrhosis	0.00116	0.00461	CbGpPWpGaD
Orlistat—DAGLB—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—primary biliary cirrhosis	0.00116	0.00459	CbGpPWpGaD
Orlistat—DAGLA—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—primary biliary cirrhosis	0.00116	0.00459	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—OGDH—primary biliary cirrhosis	0.0011	0.00437	CbGpPWpGaD
Orlistat—FASN—Metabolism—LBR—primary biliary cirrhosis	0.00108	0.00428	CbGpPWpGaD
Orlistat—FASN—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—primary biliary cirrhosis	0.00104	0.00415	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—LBR—primary biliary cirrhosis	0.00104	0.00412	CbGpPWpGaD
Orlistat—PLA2G4A—AGE/RAGE pathway—HIF1A—primary biliary cirrhosis	0.001	0.00399	CbGpPWpGaD
Orlistat—PNLIP—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	0.000991	0.00394	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—PDHX—primary biliary cirrhosis	0.00098	0.00389	CbGpPWpGaD
Orlistat—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—primary biliary cirrhosis	0.000966	0.00384	CbGpPWpGaD
Orlistat—DAGLB—liver—primary biliary cirrhosis	0.00096	0.227	CbGeAlD
Orlistat—PNLIP—Metabolism—ABCB4—primary biliary cirrhosis	0.000921	0.00366	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—DLAT—primary biliary cirrhosis	0.000921	0.00366	CbGpPWpGaD
Orlistat—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—primary biliary cirrhosis	0.000921	0.00366	CbGpPWpGaD
Orlistat—CYP3A4—Aflatoxin activation and detoxification—GGT1—primary biliary cirrhosis	0.000915	0.00364	CbGpPWpGaD
Orlistat—PLA2G4A—AGE/RAGE pathway—NOS2—primary biliary cirrhosis	0.000913	0.00363	CbGpPWpGaD
Orlistat—PNLIP—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	0.000848	0.00337	CbGpPWpGaD
Orlistat—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—primary biliary cirrhosis	0.000814	0.00324	CbGpPWpGaD
Orlistat—PLA2G7—Metabolism of proteins—AGT—primary biliary cirrhosis	0.000809	0.00322	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CDH5—primary biliary cirrhosis	0.000806	0.0032	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CDH5—primary biliary cirrhosis	0.000806	0.0032	CbGpPWpGaD
Orlistat—PLA2G4A—Platelet homeostasis—NOS2—primary biliary cirrhosis	0.000799	0.00318	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—RAD51B—primary biliary cirrhosis	0.000789	0.00314	CbGpPWpGaD
Orlistat—PLA2G4A—AGE/RAGE pathway—MMP2—primary biliary cirrhosis	0.000784	0.00312	CbGpPWpGaD
Orlistat—FASN—Metabolism—OGDH—primary biliary cirrhosis	0.000778	0.00309	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CXCR5—primary biliary cirrhosis	0.000776	0.00308	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CXCR5—primary biliary cirrhosis	0.000776	0.00308	CbGpPWpGaD
Orlistat—PLA2G7—liver—primary biliary cirrhosis	0.000775	0.183	CbGeAlD
Orlistat—PNLIP—Disease—ELMO1—primary biliary cirrhosis	0.000771	0.00307	CbGpPWpGaD
Orlistat—PNLIP—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	0.000755	0.003	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—PDE5A—primary biliary cirrhosis	0.000734	0.00292	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—NOS2—primary biliary cirrhosis	0.000712	0.00283	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—NOS2—primary biliary cirrhosis	0.000712	0.00283	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CXCL9—primary biliary cirrhosis	0.000704	0.0028	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CXCL9—primary biliary cirrhosis	0.000704	0.0028	CbGpPWpGaD
Orlistat—FASN—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	0.000701	0.00279	CbGpPWpGaD
Orlistat—FASN—Metabolism—PDHX—primary biliary cirrhosis	0.000693	0.00276	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—CXCL10—primary biliary cirrhosis	0.000684	0.00272	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—CXCL10—primary biliary cirrhosis	0.000684	0.00272	CbGpPWpGaD
Orlistat—ABHD12—liver—primary biliary cirrhosis	0.000682	0.161	CbGeAlD
Orlistat—PNLIP—liver—primary biliary cirrhosis	0.000682	0.161	CbGeAlD
Orlistat—PNLIP—Signaling Pathways—CDH5—primary biliary cirrhosis	0.000668	0.00265	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNFRSF1A—primary biliary cirrhosis	0.000664	0.00264	CbGpPWpGaD
Orlistat—PNLIP—Disease—NUP210—primary biliary cirrhosis	0.000661	0.00263	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—ELMO1—primary biliary cirrhosis	0.000652	0.00259	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—ELMO1—primary biliary cirrhosis	0.000652	0.00259	CbGpPWpGaD
Orlistat—FASN—Metabolism—ABCB4—primary biliary cirrhosis	0.000652	0.00259	CbGpPWpGaD
Orlistat—FASN—Metabolism—DLAT—primary biliary cirrhosis	0.000652	0.00259	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CXCR5—primary biliary cirrhosis	0.000643	0.00256	CbGpPWpGaD
Orlistat—PLA2G7—Metabolism of proteins—MMP2—primary biliary cirrhosis	0.000634	0.00252	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—ABCB4—primary biliary cirrhosis	0.000628	0.0025	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—CXCL10—primary biliary cirrhosis	0.000621	0.00247	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—CXCL10—primary biliary cirrhosis	0.000621	0.00247	CbGpPWpGaD
Orlistat—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—NFKB1—primary biliary cirrhosis	0.000621	0.00247	CbGpPWpGaD
Orlistat—FASN—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	0.0006	0.00239	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—ALB—primary biliary cirrhosis	0.000598	0.00238	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—ALB—primary biliary cirrhosis	0.000598	0.00238	CbGpPWpGaD
Orlistat—PLA2G4A—AGE/RAGE pathway—MMP9—primary biliary cirrhosis	0.000589	0.00234	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—CCL5—primary biliary cirrhosis	0.000589	0.00234	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—CCL5—primary biliary cirrhosis	0.000589	0.00234	CbGpPWpGaD
Orlistat—PNLIP—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	0.000588	0.00234	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CXCL9—primary biliary cirrhosis	0.000584	0.00232	CbGpPWpGaD
Orlistat—PLA2G4A—AGE/RAGE pathway—NFKB1—primary biliary cirrhosis	0.000583	0.00232	CbGpPWpGaD
Orlistat—FASN—liver—primary biliary cirrhosis	0.000572	0.135	CbGeAlD
Orlistat—DAGLA—Signaling by GPCR—MMP3—primary biliary cirrhosis	0.000566	0.00225	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—MMP3—primary biliary cirrhosis	0.000566	0.00225	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—NUP210—primary biliary cirrhosis	0.000554	0.0022	CbGpPWpGaD
Orlistat—FASN—Disease—ELMO1—primary biliary cirrhosis	0.000546	0.00217	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—ELMO1—primary biliary cirrhosis	0.00054	0.00215	CbGpPWpGaD
Orlistat—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—primary biliary cirrhosis	0.000537	0.00213	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—CCL5—primary biliary cirrhosis	0.000535	0.00213	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—CCL5—primary biliary cirrhosis	0.000535	0.00213	CbGpPWpGaD
Orlistat—FASN—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	0.000534	0.00212	CbGpPWpGaD
Orlistat—PNLIP—Disease—GOT2—primary biliary cirrhosis	0.000522	0.00208	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—ABCG2—primary biliary cirrhosis	0.000515	0.00205	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—AGT—primary biliary cirrhosis	0.000493	0.00196	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—AGT—primary biliary cirrhosis	0.000493	0.00196	CbGpPWpGaD
Orlistat—FASN—Disease—NUP210—primary biliary cirrhosis	0.000468	0.00186	CbGpPWpGaD
Orlistat—PLA2G4A—smooth muscle tissue—primary biliary cirrhosis	0.000468	0.111	CbGeAlD
Orlistat—PLA2G4A—Metabolism—LBR—primary biliary cirrhosis	0.000462	0.00183	CbGpPWpGaD
Orlistat—PNLIP—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	0.000451	0.00179	CbGpPWpGaD
Orlistat—PNLIP—Disease—GOT1—primary biliary cirrhosis	0.000451	0.00179	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—AGT—primary biliary cirrhosis	0.000447	0.00178	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—AGT—primary biliary cirrhosis	0.000447	0.00178	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—CTGF—primary biliary cirrhosis	0.000442	0.00176	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—GOT2—primary biliary cirrhosis	0.000438	0.00174	CbGpPWpGaD
Orlistat—FASN—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	0.000416	0.00165	CbGpPWpGaD
Orlistat—FASN—Metabolism—NUP210—primary biliary cirrhosis	0.000392	0.00156	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—GGT1—primary biliary cirrhosis	0.000378	0.0015	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—GOT1—primary biliary cirrhosis	0.000378	0.0015	CbGpPWpGaD
Orlistat—FASN—Disease—GOT2—primary biliary cirrhosis	0.00037	0.00147	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CXCL10—primary biliary cirrhosis	0.000367	0.00146	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CXCL10—primary biliary cirrhosis	0.000367	0.00146	CbGpPWpGaD
Orlistat—FASN—Metabolism—ABCG2—primary biliary cirrhosis	0.000364	0.00145	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—PPARGC1A—primary biliary cirrhosis	0.000336	0.00134	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—MMP3—primary biliary cirrhosis	0.000335	0.00133	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—MMP3—primary biliary cirrhosis	0.000335	0.00133	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—TYK2—primary biliary cirrhosis	0.000334	0.00133	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—TYK2—primary biliary cirrhosis	0.000334	0.00133	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—OGDH—primary biliary cirrhosis	0.000334	0.00133	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—CXCR5—primary biliary cirrhosis	0.00033	0.00131	CbGpPWpGaD
Orlistat—FASN—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	0.000319	0.00127	CbGpPWpGaD
Orlistat—FASN—Disease—GOT1—primary biliary cirrhosis	0.000319	0.00127	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CCL5—primary biliary cirrhosis	0.000316	0.00126	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CCL5—primary biliary cirrhosis	0.000316	0.00126	CbGpPWpGaD
Orlistat—PNLIP—Disease—HIF1A—primary biliary cirrhosis	0.000314	0.00125	CbGpPWpGaD
Orlistat—FASN—Metabolism—CTGF—primary biliary cirrhosis	0.000312	0.00124	CbGpPWpGaD
Orlistat—FASN—Metabolism—GOT2—primary biliary cirrhosis	0.00031	0.00123	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	0.000306	0.00122	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	0.000306	0.00122	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CXCL10—primary biliary cirrhosis	0.000304	0.00121	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	0.000301	0.0012	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—CXCL9—primary biliary cirrhosis	0.0003	0.00119	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—PDHX—primary biliary cirrhosis	0.000297	0.00118	CbGpPWpGaD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—ALB—primary biliary cirrhosis	0.000292	0.00116	CbGpPWpGaD
Orlistat—PNLIP—Disease—NOS2—primary biliary cirrhosis	0.000285	0.00113	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—DLAT—primary biliary cirrhosis	0.00028	0.00111	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—ABCB4—primary biliary cirrhosis	0.00028	0.00111	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—MMP3—primary biliary cirrhosis	0.000277	0.0011	CbGpPWpGaD
Orlistat—PNLIP—Disease—CD80—primary biliary cirrhosis	0.000277	0.0011	CbGpPWpGaD
Orlistat—FASN—Metabolism—GGT1—primary biliary cirrhosis	0.000267	0.00106	CbGpPWpGaD
Orlistat—FASN—Metabolism—GOT1—primary biliary cirrhosis	0.000267	0.00106	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—HIF1A—primary biliary cirrhosis	0.000265	0.00105	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—HIF1A—primary biliary cirrhosis	0.000265	0.00105	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—AGT—primary biliary cirrhosis	0.000264	0.00105	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—AGT—primary biliary cirrhosis	0.000264	0.00105	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—AGT—primary biliary cirrhosis	0.000262	0.00104	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CCL5—primary biliary cirrhosis	0.000262	0.00104	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	0.000258	0.00102	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	0.000254	0.00101	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—NFKB1—primary biliary cirrhosis	0.000249	0.00099	CbGpPWpGaD
Orlistat—FASN—Metabolism—PPARGC1A—primary biliary cirrhosis	0.000238	0.000945	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CD80—primary biliary cirrhosis	0.000234	0.00093	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CD80—primary biliary cirrhosis	0.000234	0.00093	CbGpPWpGaD
Orlistat—PNLIP—Disease—TYK2—primary biliary cirrhosis	0.000234	0.000929	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	0.000229	0.000911	CbGpPWpGaD
Orlistat—FASN—Disease—HIF1A—primary biliary cirrhosis	0.000222	0.000882	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—HIF1A—primary biliary cirrhosis	0.00022	0.000873	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—AGT—primary biliary cirrhosis	0.000219	0.00087	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CDH5—primary biliary cirrhosis	0.000203	0.000806	CbGpPWpGaD
Orlistat—FASN—Disease—NOS2—primary biliary cirrhosis	0.000202	0.000803	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—ALB—primary biliary cirrhosis	0.000201	0.000799	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—TYK2—primary biliary cirrhosis	0.000198	0.000785	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—TYK2—primary biliary cirrhosis	0.000198	0.000785	CbGpPWpGaD
Orlistat—FASN—Disease—CD80—primary biliary cirrhosis	0.000196	0.000779	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CXCR5—primary biliary cirrhosis	0.000195	0.000776	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CD80—primary biliary cirrhosis	0.000194	0.000771	CbGpPWpGaD
Orlistat—FASN—Metabolism—AGT—primary biliary cirrhosis	0.000185	0.000736	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—NOS2—primary biliary cirrhosis	0.000179	0.000712	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	0.000178	0.000709	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CXCL9—primary biliary cirrhosis	0.000177	0.000704	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—NUP210—primary biliary cirrhosis	0.000168	0.000668	CbGpPWpGaD
Orlistat—FASN—Disease—TYK2—primary biliary cirrhosis	0.000165	0.000657	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—ELMO1—primary biliary cirrhosis	0.000164	0.000652	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—TYK2—primary biliary cirrhosis	0.000164	0.000651	CbGpPWpGaD
Orlistat—CYP3A4—Biological oxidations—GGT1—primary biliary cirrhosis	0.000157	0.000624	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—CXCL10—primary biliary cirrhosis	0.000156	0.000621	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—ABCG2—primary biliary cirrhosis	0.000156	0.000621	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—MMP9—primary biliary cirrhosis	0.000156	0.000618	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—MMP9—primary biliary cirrhosis	0.000156	0.000618	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—NFKB1—primary biliary cirrhosis	0.000154	0.000612	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—NFKB1—primary biliary cirrhosis	0.000154	0.000612	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—ALB—primary biliary cirrhosis	0.00015	0.000598	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—MMP3—primary biliary cirrhosis	0.000143	0.000566	CbGpPWpGaD
Orlistat—FASN—Metabolism—ALB—primary biliary cirrhosis	0.000142	0.000565	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	0.000137	0.000544	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—CCL5—primary biliary cirrhosis	0.000135	0.000535	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—CTGF—primary biliary cirrhosis	0.000134	0.000533	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—GOT2—primary biliary cirrhosis	0.000133	0.000528	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—MMP9—primary biliary cirrhosis	0.000129	0.000512	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—NFKB1—primary biliary cirrhosis	0.000128	0.000507	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—GOT1—primary biliary cirrhosis	0.000115	0.000456	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—GGT1—primary biliary cirrhosis	0.000115	0.000456	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—AGT—primary biliary cirrhosis	0.000113	0.000447	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—LBR—primary biliary cirrhosis	0.000108	0.00043	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—PPARGC1A—primary biliary cirrhosis	0.000102	0.000406	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CXCL10—primary biliary cirrhosis	9.23e-05	0.000367	CbGpPWpGaD
Orlistat—CYP3A4—liver—primary biliary cirrhosis	9.07e-05	0.0214	CbGeAlD
Orlistat—PLA2G4A—Signaling Pathways—MMP3—primary biliary cirrhosis	8.42e-05	0.000335	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—TYK2—primary biliary cirrhosis	8.41e-05	0.000334	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—AGT—primary biliary cirrhosis	7.95e-05	0.000316	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CCL5—primary biliary cirrhosis	7.95e-05	0.000316	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—OGDH—primary biliary cirrhosis	7.82e-05	0.000311	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	7.7e-05	0.000306	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PDHX—primary biliary cirrhosis	6.97e-05	0.000277	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—HIF1A—primary biliary cirrhosis	6.67e-05	0.000265	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—AGT—primary biliary cirrhosis	6.65e-05	0.000264	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—DLAT—primary biliary cirrhosis	6.55e-05	0.00026	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—ABCB4—primary biliary cirrhosis	6.55e-05	0.00026	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—ALB—primary biliary cirrhosis	6.1e-05	0.000242	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CD80—primary biliary cirrhosis	5.89e-05	0.000234	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—TYK2—primary biliary cirrhosis	4.97e-05	0.000198	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—NUP210—primary biliary cirrhosis	3.94e-05	0.000156	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—MMP9—primary biliary cirrhosis	3.91e-05	0.000156	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—NFKB1—primary biliary cirrhosis	3.87e-05	0.000154	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—ABCG2—primary biliary cirrhosis	3.66e-05	0.000145	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—CTGF—primary biliary cirrhosis	3.14e-05	0.000125	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—GOT2—primary biliary cirrhosis	3.11e-05	0.000124	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—GOT1—primary biliary cirrhosis	2.69e-05	0.000107	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—GGT1—primary biliary cirrhosis	2.69e-05	0.000107	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PPARGC1A—primary biliary cirrhosis	2.39e-05	9.5e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—AGT—primary biliary cirrhosis	1.86e-05	7.4e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—ALB—primary biliary cirrhosis	1.43e-05	5.68e-05	CbGpPWpGaD
